|
2014 Journal Article End-stage kidney disease due to Alport syndrome: Outcomes in 296 consecutive Australia and New Zealand dialysis and transplant registry casesMallett, Andrew, Tang, Wen, Clayton, Philip A., Stevenson, Sarah, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil, Brown, Fiona G., Campbell, Scott B. and Johnson, David W. (2014). End-stage kidney disease due to Alport syndrome: Outcomes in 296 consecutive Australia and New Zealand dialysis and transplant registry cases. Nephrology Dialysis Transplantation, 29 (12), 2277-2286. doi: 10.1093/ndt/gfu254 |
|
2014 Journal Article Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitisCho, Yeoungjee, Badve, Sunil V., Hawley, Carmel M., McDonald, Stephen P., Brown, Fiona G., Boudville, Neil, Clayton, Philip and Johnson, David W. (2014). Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis. Nephrology, Dialysis, Transplantation, 29 (10), 1940-1947. doi: 10.1093/ndt/gfu050 |
|
2014 Journal Article Oxidative Stress-Induced alterations in PPAR-7 and associated mitochondrial destabilization contribute to kidney cell apoptosisSmall, David M., Morais, Christudas, Coombes, Jeff S., Bennett, Nigel C., Johnson, David W. and Gobe, Glenda C. (2014). Oxidative Stress-Induced alterations in PPAR-7 and associated mitochondrial destabilization contribute to kidney cell apoptosis. American Journal of Physiology - Renal Physiology, 307 (7), F814-F822. doi: 10.1152/ajprenal.00205.2014 |
|
2014 Journal Article Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department (Review)Quynh Doan, Enarson, Paul, Kissoon, Niranjan, Klassen, Terry P. and Johnson, David W. (2014). Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department (Review). Cochrane Database of Systematic Reviews, 2014 (9). doi: 10.1002/14651858.CD006452.pub4 |
|
2014 Journal Article Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational studyRossi, M., Campbell, K., Johnson, D., Stanton, T., Pascoe, E., Hawley, C., Dimeski, G., McWhinney, B., Ungerer, J. and Isbel, N. (2014). Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study. Nutrition, Metabolism and Cardiovascular Diseases, 24 (9), 1035-1042. doi: 10.1016/j.numecd.2014.04.006 |
|
2014 Journal Article Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: a multilevel logistic regression analysis using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA)Foote, Celine, Clayton, Philip A., Johnson, David W., Jardine, Meg, Snelling, Paul and Cass, Alan (2014). Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: a multilevel logistic regression analysis using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA). American Journal of Kidney Diseases, 64 (3), 359-366. doi: 10.1053/j.ajkd.2014.02.023 |
|
2014 Journal Article Economic Evaluation of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions Compared With Standard Solutions: A Secondary Analysis of the balANZ TrialHoward K., Hayes A., Cho Y., Cass A., Clarke M. and Johnson D.W. (2014). Economic Evaluation of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions Compared With Standard Solutions: A Secondary Analysis of the balANZ Trial. American Journal of Kidney Diseases, 65 (5), 773-779. doi: 10.1053/j.ajkd.2014.12.017 |
|
2014 Journal Article SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trialRossi, Megan, Johnson, David W., Morrison, Mark, Pascoe, Elaine, Coombes, Jeff S., Forbes, Josephine M., McWhinney, Brett C., Ungerer, Jacobus P. J., Dimeski, Goce and Campbell, Katrina L. (2014). SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial. BMC Nephrology, 15 (1) 106, 106.1-106.10. doi: 10.1186/1471-2369-15-106 |
|
2014 Journal Article HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysisPalmer, Suetonia C., Navaneethan, Sankar D., Craig, Jonathan C., Johnson, David W., Perkovic, Vlado, Hegbrant, Jorgen and Strippoli, Giovanni F.M. (2014). HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews, 2014 (5) CD007784. doi: 10.1002/14651858.CD007784.pub2 |
|
2014 Journal Article Treatment for peritoneal dialysis-associated peritonitisBallinger, Angela E., Palmer, Suetonia C., Wiggins, Kathryn J., Craig, Jonathan C., Johnson, David W., Cross, Nicholas B. and Strippoli, Giovanni F.M. (2014). Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database of Systematic Reviews, 2014 (4) CD005284. doi: 10.1002/14651858.CD005284.pub3 |
|
2014 Journal Article A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patientsCampbell, Katrina L., Johnson, David W., Bauer, Judith, Hawley, Carmel M., Isbel, Nicole M., Stowasser, Michael, Whitehead, Jonathan P., Dimeski, Goce and McMahon, Emma (2014). A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients. BMC Nephrology, 15 (1) 57, 57.1-57.6. doi: 10.1186/1471-2369-15-57 |
|
2014 Journal Article The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitisTang, Wen, Cho, Yeoungjee, Hawley, Carmel M., Badve, Sunil V. and Johnson, David W. (2014). The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis. Peritoneal Dialysis International, 34 (2), 219-226. doi: 10.3747/pdi.2012.00318 |
|
2014 Journal Article Does the use of neutral pH, low glucose degradation product peritoneal dialysis fluids lead to better patient outcomes?Cho, Yeoungjee and Johnson, David W. (2014). Does the use of neutral pH, low glucose degradation product peritoneal dialysis fluids lead to better patient outcomes?. Current Opinion in Nephrology and Hypertension, 23 (2), 192-197. doi: 10.1097/01.mnh.0000441046.13912.1f |
|
2014 Journal Article Biocompatible dialysis fluids for peritoneal dialysisCho, Yeoungjee, Johnson, David W., Craig, Jonathan C., Strippoli, Giovanni F.M., Badve, Sunil V. and Wiggins, Kathryn J. (2014). Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database of Systematic Reviews, 2014 (3) CD007554. doi: 10.1002/14651858.CD007554.pub2 |
|
2014 Journal Article Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysisBose, Bhadran, Badve, Sunil V., Hiremath, Swapnil S., Boudville, Neil, Brown, Fiona G., Cass, Alan, De Zoysa, Janak R., Fassett, Robert G., Faull, Randall, Harris, David C., Hawley, Carmel M., Kanellis, John, Palmer, Suetonia C., Perkovic, Vlado, Pascoe, Elaine M., Rangan, Gopala K., Walker, Robert J., Walters, Giles and Johnson, David W. (2014). Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis. Nephrology Dialysis Transplantation, 29 (2), 406-413. doi: 10.1093/ndt/gft378 |
|
2014 Journal Article Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studiesRuospo, Marinella, Palmer, Suetonia C., Craig, Jonathan C., Gentile, Giorgio, Johnson, David W., Ford, Pauline J., Tonelli, Marcello, Petruzzi, Massimo, De Benedittis, Michele and Strippoli, Giovanni F.M. (2014). Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies. Nephrology Dialysis Transplantation, 29 (2), 364-375. doi: 10.1093/ndt/gft401 |
|
2014 Journal Article HMG CoA reductase inhibitors (statins) for kidney transplant recipientsPalmer, Suetonia C., Navaneethan, Sankar D., Craig, Jonathan C., Perkovic, Vlado, Johnson, David W., Nigwekar, Sagar U., Hegbrant, Jorgen and Strippoli, Giovanni F.M. (2014). HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database of Systematic Reviews, 2014 (1) CD005019, 1-64. doi: 10.1002/14651858.CD005019.pub4 |
|
2014 Journal Article Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophyMorais, Christudas, Small, David M., Vesey, David A., Martin, Jennifer, Johnson, David W. and Gobe, Glenda C. (2014). Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy. Biochemical and Biophysical Research Communications, In Press, Corrected Proof (3), 1-6. doi: 10.1016/j.bbrc.2014.01.047 |
|
2014 Journal Article Chronic kidney disease: Haemodialysis catheter care in practiceBadve, Sunil V. and Johnson, David W. (2014). Chronic kidney disease: Haemodialysis catheter care in practice. Nature Reviews Nephrology, 10 (3), 131-133. doi: 10.1038/nrneph.2014.3 |
|
2014 Journal Article Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patientsCho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Pascoe, Elaine M., Clarke, Margaret, Topley, Nicholas and on behalf of the balANZ Trial Investigators (2014). Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients. BMC Nephrology, 15 (1) 8. doi: 10.1186/1471-2369-15-8 |
